News, views and contacts from the global Pharmaceutical industry

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

July 2016

Top

Report: Significant growth forecasted for Saudi pharmaceutical market 22 July 2016 The pharmaceutical market in Saudi Arabia is projected to grow at a compound annual growth rate (CAGR) of 7.4% to reach $6bn by 2020, an increase from $4.5bn in 2015, according to a report...

M&As this week: Hansa Medical and Knight Therapeutics 22 July 2016 Swedish-based biopharmaceutical company Hansa Medical plans to acquire the rights to cancer immunotherapy using antibody modulating enzymes, through the acquisition of glycobiology...

EC awards grant to commercialise Latima’s cancer virotherapy medicine 22 July 2016 The European Commission (EC) has awarded a grant to Latima to commercialise its cancer virotherapy medicine in the European Union (EU)...

AbCellera and MassBiologics collaborate to prevent multi-drug resistant bacteria 22 July 2016 Canadian-based biotechnology company AbCellera Biologics has entered into its third antibody discovery collaboration with US-based biotechnology company MassBiologics of the University...

Deals this week: Centre for Drug Research and Development, Taizhou Institute of Health Sciences of Fudan University, Teva Pharmaceuticals 22 July 2016 Centre for Drug Research and Development (CDRD) and AstraZeneca have entered a strategic collaboration agreement to develop improved therapies for...

Lumi and Kantar Health receive MRMW award for new mobile health survey app 21 July 2016 Mobile engagement solutions provider Lumi Technologies, in partnership with healthcare market research provider Kantar Health, has won this year’s MRMW...

UK NICE issues final guidance recommending Translarna to treat nmDMD patients 21 July 2016 The UK National Institute for Health and Care Excellence (NICE) has issued final guidance recommending US firm PTC Therapeutics’ Translarna (ataluren) to treat ambulatory patients...

Research shows early ART in HIV patients reduces heterosexual transmission 21 July 2016 A study led by the US University of North Carolina at Chapel Hill has revealed that anti-HIV medications can reduce the viral load of patients, along with providing long-term protection...

FDA approves Eisai’s Belviq XR for chronic weight management 20 July 2016 Japanese pharmaceutical company Eisai has received the US Food and Drug Administration (FDA) approval for a New Drug Application (NDA) for Belviq XR, used for chronic weight...

CDRD and AstraZeneca to develop new drug therapies for diseases with unmet medical need 20 July 2016 Canada's Centre for Drug Research and Development (CDRD) has entered into a strategic collaboration with AstraZeneca to develop new and improved therapies for better treatment of...

UK Cambridge Consultants creates new spin-out to promote DNA synthesis 20 July 2016 UK-based product design and development firm Cambridge Consultants has formed new spin-out company Evonetix with an aim to transform synthetic biology...

EMA accepts MAA review for Merck’s relapsing multiple sclerosis treatment 19 July 2016 The European Medicines Agency (EMA) has granted the review of the Marketing Authorisation Application (MAA) for American pharmaceutical company Merck’s investigational product Cladribine Tablets...

NIH study finds high levels of urinary paracetamol may affect male fertility 19 July 2016 A preliminary study conducted by researchers at the US National Institutes of Health (NIH) has revealed that high levels of paracetamol in urine may impair male...

UK Proton Partners receives investment to develop Northumberland cancer centre 19 July 2016 UK-based Proton Partners International has secured a £450,000 investment from regional growth fund programme, Let’s Grow North East, to build its Northumberland cancer centre in North East...

Boehringer Ingelheim and Dundee University partner to develop PROTAC-based drugs 18 July 2016 German pharmaceutical company Boehringer Ingelheim collaborates with the University of Dundee in Scotland in a bid to develop a new class of medicines that target disease-causing proteins...

Juno Therapeutics acquires RedoxTherapies for vipadenant licence in US 18 July 2016 US-based biopharmaceutical company Juno Therapeutics has acquired privately held, Boston-based RedoxTherapies to gain an exclusive licence for vipadenant to treat certain...

Singapore A*STAR's GIS researchers find new pathways leading to cancer progression 18 July 2016 Researchers from Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) and the Cancer Science Institute of Singapore (CSI Singapore) at the National...

M&As this week: Epiva Biosciences, Ningbo Medical System Biotechnology, Martindale Pharmaceuticals 15 July 2016 Epiva Biosciences has merged with Evelo Biosciences INC to create an immune-microbiome company for the development of therapeutics for cancer, autoimmune and inflammatory...

Health Canada initiates approval application review for Sobi’s HT-1 treatment 15 July 2016 Health Canada has initiated a review of the application for approval of healthcare company Swedish Orphan Biovitrum’s (Sobi) Orfadin (nitisinone) capsules to treat hereditary tyrosinaemia...

Queen’s University research reveals new way of treating fibromyalgia 15 July 2016 Research from Queen’s University in Kingston, Ontario, has unveiled a more effective method to treat fibromyalgia, a medical condition that causes chronic widespread pain typically accompanied...

Report: Pricing to take precedence as pharmaceutical companies strive to remain profitable within mature type 2 diabetes market 15 July 2016 The global type 2 diabetes (T2D) market is projected to reach $58.7bn by 2025, driven by competitive pricing adopted by pharmaceutical companies, according to a GlobalData...